Hippocratic AI
PrivateLast Round
Series C
Nov 4, 2025
Est. Valuation
$3.5B
Total Funding Raised
$276M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Hippocratic AI operates in Healthcare & Life Sciences and is based in Palo Alto, California. Its latest recorded funding round was a Series B round in January 2025.
Hippocratic AI is a healthcare technology company that develops a safety-focused large language model platform designed to provide conversational AI agents for clinical and administrative healthcare workflows.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Patient Engagement, NLP & Conversational AI, Vertical SaaS
Business Model
B2B
Customer Profile
Usage-Based SaaS, Marketplace Commission, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hippocratic AI Comparables
Compare Hippocratic AI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Assort Health | 81% | |
| Hyro | 80% | |
| Notable | 79% |
For institutional investors. Book with your work email.
Hippocratic AI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 4, 2025 | ||||
| Series B | Jan 9, 2025 | ||||
| Series A Extension | Sep 19, 2024 | ||||
| Series A | Mar 18, 2024 | ||||
| Seed | Jul 25, 2023 | ||||
Seed | May 16, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Hippocratic AI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A, Series B, Series C, Seed |
| SV Angel | Series A, Series B, Series C |
| Titan Ventures | Seed |
| Hakluyt Capital | Series B |
| General Catalyst | Series B, Series C, Series A, Seed |
| Greycroft | Series A Extension |
| NVentures | Series A Extension, Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 30% MoM.
- Jul 28, 2026
Pursuing FDA evaluation for AI-driven clinical agents.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesNov 2, 2026
Hippocratic AI Inc. announces Polaris 6 Ultra, a healthcare language model with six upgrades that help an AI care agent read patients’ emotional states, think mid-speech, and choose what to say next, in California on Nov 2nd '26.
- has_valuationOct 22, 2026
In late 2025, Hippocratic AI Inc. has a $3.5B valuation in United States and builds AI agents for patient phone calls, including follow-ups and scheduling.
- increases_headcount_byOct 19, 2026
Hippocratic AI Inc. increases headcount by 7 by appointing senior executives across operations, legal, government solutions, pharmaceuticals, global partnerships, marketing and finance as it expands its healthcare AI platform on Oct 19th '26.
- hiresOct 19, 2026
Hippocratic AI Inc. hires Dan Litwer as chief operating officer to support the growth and scaling of its technology platform.
- hiresOct 19, 2026
Hippocratic AI Inc. hires Greg Cioffi as chief growth officer for government solutions, with a focus on expanding its business with federal agencies and other government organizations.
For institutional investors. Book with your work email.
Hippocratic AI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hippocratic AI's valuation, stock price, and market status.
Is Hippocratic AI a public or private company?
Hippocratic AI is a private company.
What is the current stock price of Hippocratic AI?
Hippocratic AI is a private company, so its shares have no public market price. Caplight tracks Hippocratic AI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hippocratic AI worth (valuation)?
Hippocratic AI's valuation is estimated at $3.5B based on funding round data.
Can I buy Hippocratic AI stock?
Hippocratic AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hippocratic AI's last funding round?
Hippocratic AI's most recent funding round was Series C on November 4, 2025.
Who are the main investors in Hippocratic AI?
Key investors in Hippocratic AI include Andreessen Horowitz, General Catalyst, Premji Invest, Avenir Growth Capital, Kleiner Perkins.
Will Hippocratic AI IPO soon?
No public IPO plans have been announced for Hippocratic AI.
How can I track Hippocratic AI secondary market activity?
Caplight tracks bids, offers, and trades in Hippocratic AI's shares on secondary markets.